Why the study?
Do serial measurements of C-reactive protein (CRP) predict one-year cardiovascular outcomes in patients with STEMI?
Population
31 patients with ST-elevation acute myocardial infarction (STEMI)
Design
Cohort
Follow-up
one year
Authors
Loading...
Early CRP may aid STEMI risk stratification; leaves open whether serial measurements improve outcome prediction or guide therapy.
Do serial measurements of C-reactive protein (CRP) predict one-year cardiovascular outcomes in patients with STEMI?
CRP levels measured 24-72 hours after symptom onset independently predict one-year adverse cardiovascular outcomes in patients with STEMI.
Dimitrijevic et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: